Name: Allergan Inc. (NYSE:AGN.) | Balance Sheet: Assets (Quarterly)
Creator: Stock Analysis on Net

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Allergan Inc., consolidated balance sheet: assets (quarterly data)

US$ in thousands

	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013	Dec 31, 2012	Sep 30, 2012	Jun 30, 2012	Mar 31, 2012	Dec 31, 2011	Sep 30, 2011	Jun 30, 2011	Mar 31, 2011	Dec 31, 2010	Sep 30, 2010	Jun 30, 2010	Mar 31, 2010
Cash and equivalents	4,911,400)	3,910,800)	3,189,900)	2,815,300)	3,046,100)	2,686,300)	2,484,000)	2,198,800)	2,701,800)	2,655,000)	2,368,700)	2,291,700)	2,406,100)	2,212,000)	1,856,500)	2,530,800)	1,991,200)	2,603,300)	2,219,600)	1,989,700)
Short-term investments	55,000)	274,600)	525,600)	802,000)	603,000)	524,600)	184,800)	50,000)	260,600)	279,900)	304,800)	349,800)	179,900)	66,500)	299,800)	249,700)	749,100)	499,300)	—)	—)
Trade receivables, net	914,500)	967,400)	1,055,000)	990,400)	883,300)	908,200)	917,200)	887,900)	764,200)	872,600)	867,900)	855,700)	730,600)	710,900)	744,200)	671,600)	647,300)	586,900)	601,300)	558,700)
Inventories	296,000)	297,700)	299,900)	296,600)	285,300)	280,000)	274,400)	269,200)	282,900)	265,100)	259,700)	261,900)	249,700)	242,100)	242,400)	239,200)	229,400)	219,600)	201,900)	219,400)
Other current assets	694,300)	653,300)	631,300)	548,700)	493,000)	440,000)	468,200)	508,900)	449,300)	463,200)	458,500)	479,500)	482,000)	451,100)	449,700)	393,100)	376,700)	334,300)	331,400)	376,400)
Assets of discontinued operations	—)	—)	1,200)	5,700)	9,000)	93,300)	153,600)	154,700)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Current assets	6,871,200)	6,103,800)	5,702,900)	5,458,700)	5,319,700)	4,932,400)	4,482,200)	4,069,500)	4,458,800)	4,535,800)	4,259,600)	4,238,600)	4,048,300)	3,682,600)	3,592,600)	4,084,400)	3,993,700)	4,243,400)	3,354,200)	3,144,200)
Investments and other assets	271,900)	236,900)	238,700)	226,100)	213,200)	191,600)	194,400)	193,200)	192,100)	191,700)	240,400)	247,600)	247,100)	266,900)	261,600)	258,500)	261,400)	288,600)	273,400)	268,400)
Deferred tax assets	86,900)	59,400)	121,500)	121,500)	128,800)	120,200)	88,700)	74,900)	206,900)	188,300)	159,700)	149,400)	152,600)	151,400)	249,200)	242,600)	217,800)	157,100)	17,100)	6,700)
Property, plant and equipment, net	1,006,300)	1,005,300)	977,900)	942,300)	923,200)	877,000)	866,200)	853,900)	852,900)	822,800)	811,600)	807,000)	807,000)	791,100)	795,100)	788,500)	800,600)	778,000)	785,900)	795,400)
Goodwill	2,392,900)	2,414,000)	2,340,600)	2,339,400)	2,339,400)	2,334,000)	2,326,600)	2,313,200)	2,239,500)	2,092,900)	2,090,900)	2,097,300)	2,088,400)	2,093,200)	2,050,700)	2,045,300)	2,038,600)	2,043,600)	1,996,600)	2,008,400)
Intangibles, net	1,786,500)	1,826,400)	1,609,200)	1,632,200)	1,650,000)	1,689,400)	1,716,900)	1,745,800)	1,229,100)	1,079,400)	1,111,200)	1,144,300)	1,165,200)	1,198,800)	930,400)	951,400)	996,000)	1,029,400)	1,360,400)	1,405,300)
Non-current assets	5,544,500)	5,542,000)	5,287,900)	5,261,500)	5,254,600)	5,212,200)	5,192,800)	5,181,000)	4,720,500)	4,375,100)	4,413,800)	4,445,600)	4,460,300)	4,501,400)	4,287,000)	4,286,300)	4,314,400)	4,296,700)	4,433,400)	4,484,200)
Total assets	12,415,700)	11,645,800)	10,990,800)	10,720,200)	10,574,300)	10,144,600)	9,675,000)	9,250,500)	9,179,300)	8,910,900)	8,673,400)	8,684,200)	8,508,600)	8,184,000)	7,879,600)	8,370,700)	8,308,100)	8,540,100)	7,787,600)	7,628,400)

Total assets exhibited a consistent upward trajectory from March 2010 through December 2014, growing from $7.63 billion to $12.42 billion. This expansion was primarily driven by a substantial increase in current assets, particularly cash and liquid holdings, which accelerated significantly during the final two years of the period.

Liquidity and Current Asset Trends: Cash and equivalents experienced robust growth, increasing from $1.99 billion in March 2010 to $4.91 billion by December 2014. Short-term investments displayed higher volatility throughout the period, peaking at $802 million in March 2014 before declining sharply to $55 million by the end of 2014. Trade receivables showed a general upward trend, rising from $558.7 million to $914.5 million, reflecting a general expansion of the balance sheet.
Non-Current Asset Composition: Non-current assets grew from $4.48 billion to $5.54 billion. Goodwill increased steadily from $2.01 billion to $2.39 billion. A significant shift was observed in net intangibles, which declined through 2011 before experiencing a sharp increase in March 2013, rising from $1.23 billion to $1.75 billion. Property, plant, and equipment (net) maintained a stable growth pattern, surpassing the $1 billion mark in September 2014.
Operational and Structural Shifts: Inventories remained relatively stable, exhibiting only a modest increase from $219.4 million to $296.0 million over the five-year span. Assets associated with discontinued operations appeared in March 2013 at $154.7 million and were systematically reduced until they reached zero by September 2014, indicating the finalization of a divestiture process.

The overall financial position shifted toward higher liquidity, as the growth in current assets outpaced the growth in non-current assets. The simultaneous increase in goodwill and intangibles, particularly around 2013, suggests a period of strategic acquisition or asset revaluation.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Allergan Inc. (NYSE:AGN.)

Balance Sheet: AssetsQuarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data